Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CCNT2 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | decreases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CCNT2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CCNT2 mRNA | CTD | PMID:20068009 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCNT2 mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCNT2 mRNA | CTD | PMID:34747641 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of CCNT2 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of CCNT2 mRNA | CTD | PMID:21346803 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of CCNT2 mRNA | CTD | PMID:30047161 | acrolein | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CCNT2 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 | aflatoxin B1 | increases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of CCNT2 mRNA | CTD | PMID:19770486 | alpha-pinene | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CCNT2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CCNT2 mRNA | CTD | PMID:32699268 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of CCNT2 mRNA | CTD | PMID:30047161 | Aroclor 1254 | increases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CCNT2 mRNA | CTD | PMID:16934159 | Aroclor 1254 | decreases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CCNT2 mRNA | CTD | PMID:23650126 | benzene | increases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Benzene results in increased expression of CCNT2 mRNA | CTD | PMID:15929907 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of CCNT2 mRNA | CTD | PMID:26496021 | bisphenol A | decreases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CCNT2 mRNA | CTD | PMID:32156529 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CCNT2 mRNA | CTD | PMID:34947998 and PMID:35192832 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CCNT2 mRNA | CTD | PMID:27571134 and PMID:32145629 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CCNT2 mRNA | CTD | PMID:25181051 | butanal | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of CCNT2 mRNA | CTD | PMID:26079696 | cadmium atom | increases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Cadmium results in increased expression of CCNT2 mRNA | CTD | PMID:23369406 | caffeine | decreases phosphorylation | ISO | CCNT2 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of CCNT2 protein | CTD | PMID:35688186 | cerium trichloride | increases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | cerous chloride results in increased expression of CCNT2 mRNA | CTD | PMID:23573234 | chromium(6+) | increases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | chromium hexavalent ion results in increased expression of CCNT2 mRNA | CTD | PMID:27793765 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of CCNT2 mRNA | CTD | PMID:24386269 | cobalt dichloride | increases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of CCNT2 mRNA | CTD | PMID:19376846 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of CCNT2 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of CCNT2 mRNA | CTD | PMID:30556269 | copper(II) sulfate | increases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of CCNT2 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of CCNT2 mRNA | CTD | PMID:20106945 | cyclosporin A | decreases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of CCNT2 mRNA | CTD | PMID:19770486 | diazinon | affects expression | EXP | | 6480464 | Diazinon affects the expression of CCNT2 mRNA | CTD | PMID:22546817 | dibutyl phthalate | decreases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of CCNT2 mRNA | CTD | PMID:21266533 | dicrotophos | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CCNT2 mRNA | CTD | PMID:28302478 | dieldrin | affects expression | EXP | | 6480464 | Dieldrin affects the expression of CCNT2 mRNA | CTD | PMID:22546817 | divanadium pentaoxide | affects expression | ISO | CCNT2 (Homo sapiens) | 6480464 | vanadium pentoxide affects the expression of CCNT2 mRNA | CTD | PMID:17459161 | dorsomorphin | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | entinostat results in decreased expression of CCNT2 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNT2 mRNA | CTD | PMID:27188386 | folic acid | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of CCNT2 mRNA | CTD | PMID:21867686 | FR900359 | decreases phosphorylation | ISO | CCNT2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of CCNT2 protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of CCNT2 mRNA | CTD | PMID:22061828 and PMID:33387578 | glyphosate | increases expression | EXP | | 6480464 | Glyphosate results in increased expression of CCNT2 mRNA | CTD | PMID:26302742 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of CCNT2 mRNA | CTD | PMID:30047161 | methylmercury chloride | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CCNT2 mRNA | CTD | PMID:28001369 | miconazole | decreases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | Miconazole results in decreased expression of CCNT2 mRNA | CTD | PMID:27462272 | ozone | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CCNT2 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 | p-chloromercuribenzoic acid | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of CCNT2 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNT2 mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of CCNT2 mRNA | CTD | PMID:26272509 | panobinostat | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNT2 mRNA | CTD | PMID:27188386 | paracetamol | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CCNT2 mRNA | CTD | PMID:21420995 and PMID:22230336 | pentanal | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | pentanal results in decreased expression of CCNT2 mRNA | CTD | PMID:26079696 | phenylmercury acetate | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of CCNT2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNT2 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | Ccnt2 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCNT2 mRNA | CTD | PMID:19710929 | potassium chromate | increases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of CCNT2 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CCNT2 mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CCNT2 mRNA | CTD | PMID:30047161 | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CCNT2 mRNA | CTD | PMID:19228061 | resveratrol | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of CCNT2 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of CCNT2 mRNA | CTD | PMID:19073995 | sodium arsenate | increases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of CCNT2 mRNA | CTD | PMID:21795629 | sodium arsenite | affects methylation | ISO | CCNT2 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of CCNT2 gene | CTD | PMID:28589171 | succimer | multiple interactions | ISO | Ccnt2 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNT2 mRNA | CTD | PMID:21641980 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of CCNT2 mRNA | CTD | PMID:30047161 | testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of CCNT2 mRNA | CTD | PMID:26496021 | thimerosal | increases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Thimerosal results in increased expression of CCNT2 mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of CCNT2 mRNA | CTD | PMID:23770000 and PMID:26272509 | trichostatin A | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNT2 mRNA | CTD | PMID:27188386 | triptonide | increases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | triptonide results in increased expression of CCNT2 mRNA | CTD | PMID:33045310 | troglitazone | decreases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | troglitazone results in decreased expression of CCNT2 mRNA | CTD | PMID:28973697 | tunicamycin | increases expression | ISO | Ccnt2 (Mus musculus) | 6480464 | Tunicamycin results in increased expression of CCNT2 mRNA | CTD | PMID:17127020 | valproic acid | affects expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CCNT2 mRNA | CTD | PMID:25979313 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of CCNT2 mRNA | CTD | PMID:29427782 | valproic acid | multiple interactions | ISO | CCNT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNT2 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | ISO | CCNT2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CCNT2 mRNA | CTD | PMID:23179753 more ... | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of CCNT2 mRNA | CTD | PMID:23555832 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of CCNT2 mRNA | CTD | PMID:23034163 | |